0Suppliers
1Customers
0Debt Items
4Related Chains

Source-Backed Evidence Depth

Galera Therapeutics, Inc. (GRTXD) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

1Total relationships
0Distinct source URLs
0High confidence
0.720Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Galera Therapeutics, Inc. Suppliers

No suppliers on recordGalera Therapeutics, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Galera Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
SNGX Soligenix, Inc. 72% Reciprocal relationship from SNGX graph: urers of the drug substances is limited. In the event it is necessary or advisable to acquire supplies from alternative suppliers, assuming commercially reaso…

Galera Therapeutics, Inc. Debt Obligations

No debt relationships on recordNo publicly disclosed debt instruments or credit facilities found for Galera Therapeutics, Inc..

Galera Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Galera Therapeutics, Inc..

Galera Therapeutics, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Galera Therapeutics, Inc..

Galera Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SNGX Soligenix, Inc. 100.00 1 ['customer']
IPHYF Innate Pharma SA 50.00 2
UBC UBC 50.00 2
RODMAN RODMAN 50.00 2
🔐
GRTXD
Unlock GRTXD Supply Chain Data
Verified relationships include:
SNGXSoligenix, Inc.Customer72%
Subscribe — View plans →